(APUS - APIMEDS PHARMACEUTICALS US INC)

company profile

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.

Apimeds Pharmaceuticals US (APUS) is trading at 0.945

Open Price
1.55
Previous close
0.945
Previous close
0.945
P/E Ratio
0
Sector
Health Care
Shares outstanding
15091177
Primary exchange
American
ISIN
US03771D1028